NEOVASCULAR AGE RELATED MACULAR DEGENERATION (NAMD): THE EFFECT OF AFLIBERCEPT TREATMENT ON CHOROIDAL THICKNESS IN REFRACTORY NAMD PATIENTS

被引：0
|
作者：
Wijeyakumar, Wijeyanthy [1 ,2 ]
Syed, Adil [1 ,2 ]
Hong, Thomas [1 ,2 ]
Broadhead, Geoffrey K. [1 ,2 ]
Zhu, Meidong [2 ,3 ]
Chang, Andrew A. [1 ,2 ]
机构：
[1] Sydney Retina Clin & Day Surg, Sydney, NSW, Australia
[2] Sydney Inst Vis Sci, Sydney, NSW, Australia
[3] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2014年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
121
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [21] Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab
    Hsu, Jason
    Obeid, Anthony
    Mellen, Phoebe L.
    Wibbelsman, Turner D.
    Konkoly, Michelle A.
    Velez, Michael R.
    Calem, Daniel B.
    Sioufi, Kareem
    Su, Daniel
    Storey, Philip
    Klufas, Michael A.
    Spirn, Marc J.
    Regillo, Carl
    Ho, Allen C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [22] Generation of a Lentiviral Based Gene Therapy Vector for the Treatment of Neovascular Age-Related Macular Degeneration (nAMD)
    Iqball, Sharifah
    Guzman, Efrain
    Kelleher, Michelle
    Beck, Daniel
    Devarajan, Gayathri
    Khoo, Cheen
    O'Connor, Deirdre
    Harrop, Richard
    Mitrophanous, Kyriacos A.
    Lad, Yatish
    MOLECULAR THERAPY, 2021, 29 (04) : 265 - 265
  • [23] INTRAOCULAR INFLAMMATION FOLLOWING INTRAVITREAL FARICIMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD)
    Punit, Ankita Abhinandan
    Hasan, Hani
    Da Costa, Joanna
    EYE, 2024, 38 : 173 - 173
  • [24] Ranibizumab in neovascular age related macular degeneration (nAMD)-5-Year audit data
    Prakash, Priya
    Dorairaj, Paul
    Chittajulu, Nivedita
    Butt, Adil
    Ghaloo, Anila
    Cheema, Ravinder Singh
    EYE, 2017, 31 : S7 - S8
  • [25] Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
    Sarkar, Aira
    Junnuthula, Vijayabhaskarreddy
    Dyawanapelly, Sathish
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [26] Relationship of Retinal morphology and Sensitivity in Neovascular Age-related Macular Degeneration (NAMD). Comparision of Ranibizumab versus Aflibercept treatment over 1 year
    Sulzbacher, Florian
    Sacu, Stefan
    Roberts, Philipp Ken
    Munk, Marion Ronit
    Kroh, Maria Elisabeth
    Kaider, Alexandra
    Rezar, Sandra
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [27] Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV)
    Zhao, Min
    Bai, Yujing
    Xie, Wankun
    Shi, Xuan
    Li, Fangting
    Yang, Fei
    Sun, Yaoyao
    Huang, Lvzhen
    Li, Xiaoxin
    PLOS ONE, 2015, 10 (05):
  • [28] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Ki Woong Bae
    Dong Ik Kim
    Daniel Duck-Jin Hwang
    Scientific Reports, 12
  • [29] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Bae, Ki Woong
    Kim, Dong Ik
    Hwang, Daniel Duck-Jin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in neovascular age related macular degeneration (nAMD)
    Rafijah, Neala
    Shah, Parth Arvind
    Tang, Yannan
    Willis, Jeffrey
    Kotecha, Aachal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345